MD Biosciences Neuro is a preclinical and translational contract research organization (CRO) offering services for drug development in the field of neurology and pain research. We understand that finding a trust-worthy preclinical partner is a top priority for drug developers and believe that you should have confidence in the partner you choose. That’s why we are dedicated to providing each client valued expertise and advice, experience for flawless execution, and flexibility to meet the needs of rapidly changing requirements.

With a presence in the innovation hubs of Cambridge, Massachusetts and with state of the art laboratories in Israel, our team is dedicated to building collaborative programs and creating lasting partnerships in the biotechnology community.

Newly built in 2021, our 20,000 square feet CNS research facility was purpose-built for translational CNS research and boasts dedicated wings for rodent research, translational pig research, and in vitro biomarker research. Each wing contains custom housing facilities along with expertly designed surgical suites, treatment rooms, and behavioral suites that minimize environmental stress factors that can impact CNS and pain studies.